Logo do repositório
 
Publicação

Influenza vaccine effectiveness in the portuguese elderly during 2016-17 season

dc.contributor.authorGómez, Verónica
dc.contributor.authorSousa-Uva, Mafalda
dc.contributor.authorConde, Patrícia
dc.contributor.authorKislaya, Irina
dc.contributor.authorGomes, Victor
dc.contributor.authorPoças, José
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorNunes, Baltazar
dc.contributor.authorMachado, Ausenda
dc.date.accessioned2018-02-26T16:36:30Z
dc.date.available2019-12-31T01:30:11Z
dc.date.issued2017-09-07
dc.description.abstractEvery year the influenza vaccine is reformulated,so estimating the influenza vaccine effectiveness (IVE) every season in an early stage is of major importance to support public health decisions. Since 2008-09, Portugal and other European countries implemented a common protocol using the test negative design (TND) at Primary Care level (PC) and since 2015-16 at Hospital Level (HL), framed by the IMOVE+ multicentric study. We aimed to estimate IVE against confirmed medically attended influenza and against confirmed hospitalized influenza in the Portuguese population aged 65 years or more, during the 2016-17 season. We used the TND in both PC and HL. For the PC setting, medically attended influenza positive patients were compared to influenza negative patients, whereas at HL laboratory confirmed influenza positive SARI patients were compared to negative ones. Epidemiological data was collected via questionnaire and the influenza (type/subtype) diagnosis in nasopharyngeal swabs by RT-PCR. The set of collected variables included sociodemographics, chronic conditions, health behaviour, severity, previous influenza and pneumococcal vaccination, functional status, health seeking behaviour and belonging to target group for vaccination. IVE was estimated as 1 – OR of being vaccinated in cases vs controls, adjusted for age, having 2 or more underlying conditions and time trough non-conditional logistic regression. The adjusted IVE was 11% in the Primary Care setting and 49% in Hospital Level, which indicates a low protection of the seasonal 2016/17 vaccine in the elderly population. Even though the small sample size should be considered in the interpretation of results, it should be noted that the IVE estimates are according to results from IMOVE+ study group and other international estimates. A suboptimal IVE against influenza A(H3N2) continues to be observed as in previous seasons.pt_PT
dc.description.sponsorshipThe IMOVE+ project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/5077
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherInstituto Nacional de Saúde Doutor Ricardo Jorge, IPpt_PT
dc.relationI-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
dc.subjectGripept_PT
dc.subjectVaccine Effectivenesspt_PT
dc.subjectInfluenzapt_PT
dc.subjectInfluenza Vaccinept_PT
dc.subjectVacina Antigripalpt_PT
dc.subjectI-MOVE+pt_PT
dc.subjectEstados de Saúde e de Doençapt_PT
dc.subjectInfecções Respiratóriaspt_PT
dc.titleInfluenza vaccine effectiveness in the portuguese elderly during 2016-17 seasonpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitleI-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly
oaire.awardURIinfo:eu-repo/grantAgreement/EC/H2020/634446/EU
oaire.citation.conferencePlaceBarcelona, Espanhapt_PT
oaire.citation.titleXXXV Reunião Anual da Sociedade Espanhola de Epidemiología (SEE) e XII Congresso da Associação Portuguesa de Epidemiologia (APE), 6-8 Septiembre 2017pt_PT
oaire.fundingStreamH2020
project.funder.identifierhttp://doi.org/10.13039/501100008530
project.funder.nameEuropean Commission
rcaap.rightsembargoedAccesspt_PT
rcaap.typeconferenceObjectpt_PT
relation.isProjectOfPublicationccfd73a6-6f3c-4702-956c-544973bca97d
relation.isProjectOfPublication.latestForDiscoveryccfd73a6-6f3c-4702-956c-544973bca97d

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
C594_Gómez_IMOVE+.pdf
Tamanho:
962.42 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: